These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9488204)

  • 1. Accelerated arteriosclerosis after transplantation: the possible role of calcium channel blockers.
    Atkinson JB
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S125-34. PubMed ID: 9488204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium blockers and atherosclerosis: lessons from the Stanford Transplant Coronary Artery Disease/Diltiazem Trial.
    Schroeder JS; Gao SZ
    Can J Cardiol; 1995 Sep; 11(8):710-5. PubMed ID: 7671182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural evidence of cell-mediated endothelial cell injury in cardiac transplant-related accelerated arteriosclerosis.
    Young-Ramsaran JO; Hruban RH; Hutchins GM; Phelps TH; Baumgartner WA; Reitz BA; Olson JL
    Ultrastruct Pathol; 1993; 17(2):125-36. PubMed ID: 8316962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blockers and coronary atherosclerosis: from the rabbit to the real world.
    Waters D; Lespérance J
    Am Heart J; 1994 Dec; 128(6 Pt 2):1309-16. PubMed ID: 7977012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients.
    Schroeder JS; Gao SZ; Alderman EL; Hunt SA; Johnstone I; Boothroyd DB; Wiederhold V; Stinson EB
    N Engl J Med; 1993 Jan; 328(3):164-70. PubMed ID: 8417382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft.
    Koskinen P; Lemstrøm K; Mattila S; Häyry P; Nieminen MS
    Clin Transplant; 1996 Dec; 10(6 Pt 1):487-93. PubMed ID: 8996768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
    Zannad F
    Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunocytochemical investigations of cardiac and vessel allograft arteriosclerosis using smooth muscle cell and macrophage-specific monoclonal antibodies].
    Sasaguri S
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1840-7. PubMed ID: 2608013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated graft coronary artery disease: diagnosis and prevention.
    Schroeder JS; Gao SZ; Hunt SA; Stinson EB
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S258-65. PubMed ID: 1515448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The smooth muscle cell membrane during atherogenesis: a potential target for amlodipine in atheroprotection.
    Tulenko TN; Sumner AE; Chen M; Huang Y; Laury-Kleintop L; Ferdinand FD
    Am Heart J; 2001 Feb; 141(2 Suppl):S1-11. PubMed ID: 11174352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blockers and atherosclerosis.
    Sowers JR
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):3-9. PubMed ID: 2220798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allograft vasculopathy versus atherosclerosis.
    Rahmani M; Cruz RP; Granville DJ; McManus BM
    Circ Res; 2006 Oct; 99(8):801-15. PubMed ID: 17038650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo university (ALPS-J).
    Miyauchi K; Kojima T; Yokoyama T; Kurata T; Yokoyama K; Kawamura M; Suwa S; Okazaki S; Inoue K; Fujiwara Y; Sumiyoshi M; Tanimoto K; Nakazato Y; Yamagami S; Daida H
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):409-13. PubMed ID: 19763803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
    Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amlodipine on gene expression and extracellular matrix formation in human vascular smooth muscle cells and fibroblasts: implications for vascular protection.
    Eickelberg O; Roth M; Block LH
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S31-7. PubMed ID: 9488193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The continuing challenge of cardiac transplant arteriosclerosis.
    Weis M; Meiser BM; Reichart B; von Scheidt W
    Cardiologia; 1998 Aug; 43(8):777-87. PubMed ID: 9808867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis.
    Hruban RH; Beschorner WE; Baumgartner WA; Augustine SM; Ren H; Reitz BA; Hutchins GM
    Am J Pathol; 1990 Oct; 137(4):871-82. PubMed ID: 1699422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atheroprotection with amlodipine: cells to lesions and the PREVENT trial. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial.
    Tulenko TN; Brown J; Laury-Kleintop L; Khan M; Walter MF; Mason RP
    J Cardiovasc Pharmacol; 1999; 33 Suppl 2():S17-22. PubMed ID: 10071259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery ultrastructural changes in cardiac transplant atherosclerosis in the rabbit.
    Kuwahara M; Jacobsson J; Kuwahara M; Kagan E; Ramwell PW; Foegh ML
    Transplantation; 1991 Nov; 52(5):759-65. PubMed ID: 1949159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.